Jaji, Absar .

HRN: 17-61-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
CEFUROXIME 750MG (VIAL)
07/23/2026
07/30/2026
IV
1.5 Gm
On Call To OR
Elective Fistulectomy
Remove - Pending Acceptance
07/24/2026
CEFUROXIME 1.5GM (VIAL)
07/24/2026
07/30/2026
IV
1.5g
Q8
Fistula-in-ano
Remove - Pending Acceptance
07/24/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2026
07/30/2026
IV
500mg
Q8
Fistula-in-ano
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: